Close Menu

NEW YORK (GenomeWeb) – Sygnis today announced that it has raised €5 million ($6.2 million) in a rights offering to German and international institutional investors.

The company said the subscription ratio in the offering was 13:3, meaning 13 existing shares entitled the shareholder to subscribe for three new shares in the firm. The subscription price was €2 per share. Shares that were not subscribed in the rights offering were offered to select German and international institutional investors at the same price.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.